Title: Fredrik Pontèn: Innovator in Breast Cancer Prognostics
Introduction
Fredrik Pontèn is an accomplished inventor based in Uppsala, Sweden. He is associated with Atlas Antibodies AB, where he contributes to advancements in medical research. His work primarily focuses on breast cancer prognostics and treatment prediction.
Latest Patent Applications
Fredrik Pontèn has made significant strides in the field with his patent application titled "ANLN PROTEIN AS AN ENDOCRINE TREATMENT PREDICTIVE FACTOR." This invention provides methods, uses, and means for breast cancer prognostics and treatment prediction. The methods involve evaluating the amount of ANLN protein present in a sample obtained from a breast cancer subject. By comparing the sample value with a reference value, it can be determined whether the subject is likely to benefit from endocrine treatment.
Conclusion
Fredrik Pontèn's innovative work in breast cancer prognostics highlights the importance of research in improving treatment outcomes. His contributions are paving the way for advancements in medical science.